FibroGen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.

CEO

Thane Wettig

CEOThane Wettig

Employees

225

Employees225

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

1993

Founded1993

Employees

225

Employees225

FGEN Key Statistics

Market cap

31.14M

Market cap31.14M

Price-Earnings ratio

-3.02

Price-Earnings ratio-3.02

Dividend yield

—

Dividend yield—

Average volume

768.04K

Average volume768.04K

High today

$0.3104

High today$0.3104

Low today

$0.30

Low today$0.30

Open price

$0.30

Open price$0.30

Volume

585.49K

Volume585.49K

52 Week high

$1.53

52 Week high$1.53

52 Week low

$0.18

52 Week low$0.18

FGEN News

Simply Wall St 4d

FibroGen First Quarter 2025 Earnings: Beats Expectations

FibroGen ( ) First Quarter 2025 Results Key Financial Results Net loss: US$16.8m (loss narrowed by 49% from 1Q 2024). US$0.17 loss per share (improved from U...

People also own

Based on the portfolios of people who own FGEN. This list is generated using Robinhood data, and it’s not a recommendation.